Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IOFLUPANE I-123: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

46.4%
Female
53.6%
Male

Age Information

The average age of patients reporting adverse events with IOFLUPANE I-123 is 61.7 years.

Geographic Distribution

The majority of adverse event reports for IOFLUPANE I-123 originate from US.

Report Summary & Outcomes

34
Total Reports
34
As Primary/Secondary Suspect
0
Deaths Reported
0
Hospitalizations

Reporting Timeline

First adverse event report: 20220824. Most recent report: 20250808. View full timeline →

More About IOFLUPANE I-123

IOFLUPANE I-123 Full Profile Reports by Year Drug Interactions